Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses
The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Abstract
Dual-specificity phosphatases (DUSPs) are a subset of protein tyrosine phosphatases, many of which dephosphorylate threonine and tyrosine residues on mitogen-activated protein kinases (MAPKs), and hence are also referred to as MAPK phosphatases (MKPs). The regulated expression and activity of DUSP family members in different cells and tissues controls MAPK intensity and duration to determine the type of physiological response. For immune cells, DUSPs regulate responses in both positive and negative ways, and DUSP-deficient mice have been used to identify individual DUSPs as key regulators of immune responses. From a drug discovery perspective, DUSP family members are promising drug targets for manipulating MAPK-dependent immune responses in a cell-type and disease-context-dependent manner, to either boost or subdue immune responses in cancers, infectious diseases or inflammatory disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MAPKs are involved in multiple cellular processes, such as cell differentiation, proliferation, apoptosis, inflammation, stress responses, and immune defense [ 4 ].”
From MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges (2023) · cites this paper as [4]
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
Lee, J. C., Laydon, J. T., McDonnell, P. C., Gallagher, T. F., Kumar, S., Green, D., McNulty, D., Blumenthal, M. J., Keys, J. R., Land vatter, S. W., et al. (1994) · Nature · doi:10.1038/372739a0 · Cited by 3,288
Roux, P. P., & Blenis, J. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.2.320-344.2004 · Cited by 2,490
Mitogen-activated protein kinase pathways
Robinson, M. J., & Cobb, M. H. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80061-0 · Cited by 2,474
Protein Tyrosine Phosphatases in the Human Genome
Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Friedberg, I., Osterman, A., Godzik, A., Hunter, T., Dixon, J., & Mustelin, T. (2004) · Cell · doi:10.1016/j.cell.2004.05.018 · Cited by 1,886
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Cited by
MET signalling: principles and functions in development, organ regeneration and cancer
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3012 · Cited by 1,240
Dual-specificity phosphatases: critical regulators with diverse cellular targets
Patterson, K. I., Brummer, T., O'brien, P. M., & Daly, R. J. (2009) · Biochemical Journal · doi:10.1042/bj20082234 · Cited by 744
Keshet, Y., & Seger, R. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-795-2_1 · Cited by 642
Signaling pathways underlying the rapid antidepressant actions of ketamine
Duman, R. S., Li, N., Liu, R.-J., Duric, V., & Aghajanian, G. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.044 · Cited by 537
Dual‐specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling
Caunt, C. J., & Keyse, S. M. (2013) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08716.x · Cited by 535
MAPKs and their relevance to arthritis and inflammation
Thalhamer, T., McGrath, M. A., & Harnett, M. M. (2007) · Rheumatology · doi:10.1093/rheumatology/kem297 · Cited by 460
Elusive roles for reactive astrocytes in neurodegenerative diseases
Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
A negative regulator of MAP kinase causes depressive behavior
Duric, V., Banasr, M., Licznerski, P., Schmidt, H. D., Stockmeier, C. A., Simen, A. A., Newton, S. S., & Duman, R. S. (2010) · Nature Medicine · doi:10.1038/nm.2219 · Cited by 412
Regulation of JNK and p38 MAPK in the immune system: Signal integration, propagation and termination
Huang, G., Shi, L. Z., & Chi, H. (2009) · Cytokine · doi:10.1016/j.cyto.2009.08.002 · Cited by 368
Vandevyver, S., Dejager, L., Tuckermann, J., & Libert, C. (2013) · Endocrinology · doi:10.1210/en.2012-2045 · Cited by 296
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitors.
Ercan, D., Xu, C., Yanagita, M., Monast, C. S., Pratilas, C. A., Montero, J., Butaney, M., Shimamura, T., Sholl, L., Ivanova, E. V., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0103 · Cited by 294
“One of the most downregulated genes in H1975 WZR cells compared to H1975 cells was DUSP6, a dual specific phosphatase that negatively regulates ERK 1/2 phosphorylation (23).”
BackgroundModeling precision treatment of breast cancer
Daemen, A., Griffith, O. L., Heiser, L. M., Wang, N. J., Enache, O. M., Sanborn, Z., Pepin, F., Durinck, S., Korkola, J. E., Griffith, M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r110 · Cited by 295
PharmGKB summary: cyclosporine and tacrolimus pathways
Barbarino, J. M., Staatz, C. E., Venkataramanan, R., Klein, T. E., & Altman, R. B. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328364db84 · Cited by 257
DUSPs, to MAP kinases and beyond
Huang, C.-Y., & Tan, T.-H. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-24 · Cited by 260
Bcl-6 and NF-κB cistromes mediate opposing regulation of the innate immune response
Barish, G. D., Yu, R. T., Karunasiri, M., Ocampo, C. B., Dixon, J., Benner, C., Dent, A. L., Tangirala, R. K., & Evans, R. M. (2010) · Genes & Development · doi:10.1101/gad.1998010 · Cited by 256
Flavonoids in Inflammatory Bowel Disease: A Review
Vezza, T., Rodríguez-Nogales, A., Algieri, F., Utrilla, M., Rodriguez-Cabezas, M., & Galvez, J. (2016) · Nutrients · doi:10.3390/nu8040211 · Cited by 241
Qiu, S., Xie, L., Lu, C., Gu, C., Xia, Y., Lv, J., Xuan, Z., Fang, L., Yang, J., Zhang, L., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02499-8 · Cited by 214
NLRP3 gene knockout blocks NF-κB and MAPK signaling pathway in CUMS-induced depression mouse model
Su, W.-J., Zhang, Y., Chen, Y., Gong, H., Lian, Y.-J., Peng, W., Liu, Y.-Z., Wang, Y.-X., You, Z.-L., Feng, S.-J., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.01.018 · Cited by 215
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signaling
Wagner, K. W., Alam, H., Dhar, S. S., Giri, U., Li, N., Wei, Y., Giri, D., Cascone, T., Kim, J.-H., Ye, Y., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68642 · Cited by 193
Zhang, Z., Kobayashi, S., Borczuk, A. C., Leidner, R. S., LaFramboise, T., Levine, A. D., & Halmos, B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq020 · Cited by 186
Mitogen activated protein kinases: a role in inflammatory bowel disease?
Broom, O. J., Widjaya, B., Troelsen, J., Olsen, J., & Nielsen, O. H. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04033.x · Cited by 177
Moussaieff, A., & Mechoulam, R. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.10.0003 · Cited by 174
Advances in mechanisms and signaling pathways of carbon nanotube toxicity
Dong, J., & Ma, Q. (2015) · Nanotoxicology · doi:10.3109/17435390.2015.1009187 · Cited by 169
Li, Z., Fei, T., Zhang, J., Zhu, G., Wang, L., Lu, D., Chi, X., Teng, Y., Hou, N., Yang, X., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.016 · Cited by 162
Functions of p38 MAP Kinases in the Central Nervous System
Asih, P. R., Prikas, E., Stefanoska, K., Tan, A. R. P., Ahel, H. I., & Ittner, A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.570586 · Cited by 174
Mu, Y., Ding, F., Cui, P., Ao, J., Hu, S., & Chen, X. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-506 · Cited by 158
Balko, J. M., Schwarz, L. J., Bhola, N. E., Kurupi, R., Owens, P., Miller, T. W., Gómez, H., Cook, R. S., & Arteaga, C. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1385 · Cited by 163
Dual-Specificity Phosphatases in Immunity and Infection: An Update
Lang, R., & Raffi, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112710 · Cited by 160
Bachstetter, A. D., & Eldik, L. J. V. (2010) · PubMed · Cited by 211
Lü, D., Liu, L., Ji, X., Gao, Y., Chen, X., Liu, Y., Liu, Y., Zhao, X., Li, Y., Li, Y., et al. (2015) · Nature Immunology · doi:10.1038/ni.3278 · Cited by 163
Laiño, J., Villena, J., Kanmani, P., & Kitazawa, H. (2016) · Microorganisms · doi:10.3390/microorganisms4030027 · Cited by 156
Nairismägi, M., Tan, J. Y., Lim, J. Q., Nagarajan, S., Ng, C. C. Y., Rajasegaran, V., Huang, D., Lim, W. K., Laurensia, Y., Wijaya, G.-C., et al. (2016) · Leukemia · doi:10.1038/leu.2016.13 · Cited by 149
Molecular Pathways and Mechanisms of BRAF in Cancer Therapy
Poulikakos, P. I., Sullivan, R. J., & Yaeger, R. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2138 · Cited by 145
McKernan, D. P., Dinan, T. G., & Cryan, J. F. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.04.006 · Cited by 147
Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease
Wancket, L. M., Frazier, W. J., & Liu, Y. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.11.017 · Cited by 137
Klotz, C., Ziegler, T. R., Figueiredo, A. S., Rausch, S., Hepworth, M. R., Obsivac, N., Sers, C., Lang, R., Hammerstein, P., Lucius, R., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001248 · Cited by 144
TLR Cross-talk Confers Specificity to Innate Immunity
Tan, R. S. T., Ho, B., Leung, B. P. L., & Ding, J. L. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.921164 · Cited by 129
Ribot, J. C., Ribeiro, S. T., Correia, D. V., Sousa, A. E., & Silva‐Santos, B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303119 · Cited by 129
Zheng, X., Vis, D. J., Bruna, A., Šuštić, T., van Wageningen, S., Batra, A. S., Rueda, O. M., Bosdriesz, E., Caldas, C., Wessels, L. F. A., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0044-4 · Cited by 126
Chemotherapy and signaling: How can targeted therapies supercharge cytotoxic agents?
Bagnyukova, T., Serebriiskii, I. G., Zhou, Y., Hopper-Borge, E. A., Golemis, E. A., & Astsaturov, I. A. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.9.13738 · Cited by 143
Oh, S. E., & Mouradian, M. M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.09.008 · Cited by 126
Comfort, K. K., Maurer, E. I., Braydich‐Stolle, L. K., & Hussain, S. M. (2011) · ACS Nano · doi:10.1021/nn203785a · Cited by 115
Fibroblast growth factor signaling in development of the cerebral cortex
Iwata, T., & Hevner, R. F. (2009) · Development Growth & Differentiation · doi:10.1111/j.1440-169x.2009.01104.x · Cited by 114
Yu, Y., & Richardson, D. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.225946 · Cited by 110
The MAPK Pathway-Based Drug Therapeutic Targets in Pituitary Adenomas
Lu, M., Ya, W., & Zhan, X. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00330 · Cited by 108
Yu, M., Li, G., Lee, W.-W., Yuan, M., Cui, D., Weyand, C. M., & Goronzy, J. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109797109 · Cited by 102
Kano, G., Almanan, M., Bochner, B. S., & Zimmermann, N. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.03.024 · Cited by 101
Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines
Schmitz, M. L., Weber, A., Roxlau, T., Gaestel, M., & Kracht, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.06.019 · Cited by 99
Kesarwani, M., Kincaid, Z., Gomaa, A. R., Huber, E., Rohrabaugh, S., Siddiqui, Z., Bouso, M. F., Latif, T., Xu, M., Komurov, K., et al. (2017) · Nature Medicine · doi:10.1038/nm.4310 · Cited by 98
Salerno, P., Falco, V. D., Tamburrino, A., Nappi, T. C., Vecchio, G., Schweppe, R. E., Bollag, G. E., Santoro, M. M., & Salvatore, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0373 · Cited by 98
Protein tyrosine phosphatases: dual‐specificity phosphatases in health and disease
Pulido, R., & van Huijsduijnen, R. H. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06250.x · Cited by 108
Lu, H., Tran, T. M. L., Park, Y., Chen, I., Lan, J., Xie, Y., & Semenza, G. L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0270 · Cited by 99
Spatiotemporal Regulation of ERK2 by Dual Specificity Phosphatases
Caunt, C. J., Armstrong, S. P., Rivers, C. A., Norman, M. R., & McArdle, C. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801500200 · Cited by 96
Role of Dual Specificity Phosphatases in Biological Responses to Glucocorticoids
Clark, A. R., Martins, J. R. S., & Tchen, C. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r700053200 · Cited by 104
Jeong, Y., Du, R., Zhu, X., Yin, S., Wang, J., Cui, H., Cao, W., & Lowenstein, C. J. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1013565 · Cited by 101
Dick, O., & Bading, H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.127654 · Cited by 93
Cagnol, S., & Rivard, N. (2012) · Oncogene · doi:10.1038/onc.2012.88 · Cited by 94
Axon injury signaling and compartmentalized injury response in glaucoma
Syc‐Mazurek, S. B., & Libby, R. T. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.002 · Cited by 99
Wu, S., Yano, S., Chen, J., Hisanaga, A., Sakao, K., He, X., He, J., & Hou, D. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b01599 · Cited by 89
Post-translational regulation of the ERK phosphatase DUSP6/MKP3 by the mTOR pathway
Bermúdez, O. M., Marchetti, S., Pagès, G., & Gimond, C. (2008) · Oncogene · doi:10.1038/sj.onc.1211040 · Cited by 86
Dusp-5 and Snrk-1 coordinately function during vascular development and disease
Pramanik, K., Chun, C. Z., Garnaas, M., Samant, G. V., Li, K., Horswill, M. A., North, P. E., & Ramchandran, R. (2008) · Blood · doi:10.1182/blood-2008-06-162180 · Cited by 83
Dual-Specificity Phosphatases as Molecular Targets for Inhibition in Human Disease
Ríos, P., Nunes‐Xavier, C. E., Tabernero, L., Köhn, M., & Pulido, R. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5709 · Cited by 96
Barthas, F., Humo, M., Gilsbach, R., Waltisperger, E., Karatas, M., Leman, S., Hein, L., Belzung, C., Boutillier, A., Barrot, M., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.019 · Cited by 83
Đurić, V., & Duman, R. S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1020-7 · Cited by 86
Wang, Y., Han, D. H., Zhou, T., Chen, C., Cao, H., Zhang, J. Z., Ma, N., Liu, C., Song, M., Shi, J., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab316 · Cited by 81
Taxman, D. J., Holley-Guthrie, E., Huang, M. T.-H., Moore, C. B., Bergstralh, D. T., Allen, I. C., Lei, Y. L., Gris, D., & Ting, J. P.-Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.221077 · Cited by 83
Boulding, T., Wu, F., McCuaig, R., Dunn, J., Sutton, C. R., Hardy, K., Tu, W., Bullman, A., Yip, D., Dahlstrom, J. E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148065 · Cited by 76
Lü, X., Li, Y., Li, X., & Aisa, H. A. (2017) · Oncology Letters · doi:10.3892/ol.2017.6380 · Cited by 76
CD4 + T cells aggravate hemorrhagic brain injury
Shi, S. X.-Y., Xiu, Y., Li, Y., Yuan, M., Shi, K., Liu, Q., Wang, X., & Jin, W.-N. (2023) · Science Advances · doi:10.1126/sciadv.abq0712 · Cited by 83
Cardoso, K. C., da Silva, M. J., Costa, G. G., Torres, T. T., Del‐Bem, L., Vidal, R. O., Menossi, M., & Hyslop, S. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-605 · Cited by 76
Rushworth, L. K., Kidger, A. M., Delavaine, L., Stewart, G., van Schelven, S., Davidson, J., Bryant, C., Caddye, E., East, P., Caunt, C. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420159112 · Cited by 75
Hwang, T., Aljuffali, I. A., Hung, C., Chen, C., & Fang, J. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.011 · Cited by 73
Epidermal Growth Factor Receptor and Protein Kinase C Signaling to ERK2
Caunt, C. J., Rivers, C. A., Conway-Campbell, B. L., Norman, M. R., & McArdle, C. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706624200 · Cited by 73
Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants
Pathak, D., & Sriram, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032272 · Cited by 77
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2018.11.001 · Cited by 71
Dysregulation of p38 and MKP-1 in Response to NOD1/TLR4 Stimulation in Sarcoid Bronchoalveolar Cells
Rastogi, R., Du, W., Ju, D., Pirockinaite, G., Liu, Y., Núñez, G., & Samavati, L. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0792oc · Cited by 71
Chen, C.-C., Hardy, D. B., & Mendelson, C. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295865 · Cited by 70
Toska, E., Castel, P., Chhangawala, S., Arruabarrena-Aristorena, A., Chan, C., Hristidis, V. C., Cocco, E., Sallaku, M., Xu, G., Park, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.111 · Cited by 71
Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells
Pérez‐Sen, R., Queipo, M. J., Gil‐Redondo, J. C., Ortega, F., Gómez‐Villafuertes, R., Miras‐Portugal, M. T., & Delicado, E. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081999 · Cited by 72
Huang, C., Lin, Y., Hsiao, W., Liao, F., Huang, P., & Tan, T. (2011) · European Journal of Immunology · doi:10.1002/eji.201041295 · Cited by 68
Cheng, Q., Fan, H., Ngo, D., Beaulieu, É., Leung, P. S. C., Lo, C. Y.-W., Burgess, R., van der Zwan, Y. G., White, S. J., Khachigian, L. M., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202662 · Cited by 68
Bellou, S., Hink, M. A., Bagli, E., Panopoulou, E., Bastiaens, P. I. H., Murphy, C., & Fotsis, T. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00058.2009 · Cited by 68
Li, C., Zhou, Q., Yang, L.-C., Chen, Y.-H., Hou, J., Guo, K., Wang, Y., & Li, Y. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0536-7 · Cited by 68
Luo, Z. (2011) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01713.x · Cited by 68
MAPK phosphatase-1 facilitates the loss of oxidative myofibers associated with obesity in mice
Flach, R. J. R., Le, A. M., Zhang, L., Kahn, M., Samuel, V. T., Shulman, G. I., & Bennett, A. M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39054 · Cited by 67
Xiang, Q.-D., Yu, Q., Wang, H., Zhao, M.-M., Liu, S., Nie, S., & Xie, M. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b01763 · Cited by 64
MAPK Pathways in Ocular Pathophysiology: Potential Therapeutic Drugs and Challenges
Moustardas, P., Aberdam, D., & Lagali, N. (2023) · Cells · doi:10.3390/cells12040617 · Cited by 63
“cellular processes, such as cell differentiation, proliferation, apoptosis, inflammation, stress responses, and immune defense [4].”
BackgroundPharmacological Targeting of the Mitochondrial Phosphatase PTPMT1
Doughty-Shenton, D., Joseph, J. D., Zhang, J., Pagliarini, D. J., Kim, Y., Lu, D., Dixon, J. E., & Casey, P. J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163329 · Cited by 63
Dual Specificity Phosphatase 4 Mediates Cardiomyopathy Caused by Lamin A/C (LMNA) Gene Mutation
Choi, J. C., Wu, W., Muchir, A., Iwata, S., Homma, S., & Worman, H. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.404541 · Cited by 63
Multiple actions of lysophosphatidic acid on fibroblasts revealed by transcriptional profiling
Stortelers, C., Kerkhoven, R. M., & Moolenaar, W. H. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-387 · Cited by 62
Shin, S., Park, S.-Y., & Kang, G. H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.004 · Cited by 66
Zhu, J., Shen, W., Li, G., Gu, H., Shen, S., Wang, Y., Wu, H., & Guo, J. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-1 · Cited by 62
Epigallocatechin-3-gallate (EGCG) protects against chromate-induced toxicity in vitro
Wu, F., Sun, H., Kluz, T., Clancy, H. A., Kiok, K., & Costa, M. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.018 · Cited by 62
Graphene quantum dots inhibit T cell-mediated neuroinflammation in rats
Tasić, J., Stanojević, Ž., Vidičević, S., Isaković, A., Ćirić, D., Martinović, T., Kravic‐Stevovic, T., Bumbasirevic, V. Z., Paunović, V., Jovanović, S., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.030 · Cited by 62
Mkp1Is a c-Jun Target Gene That Antagonizes JNK-Dependent Apoptosis in Sympathetic Neurons
Kristiansen, M., Hughes, R., Patel, P., Jacques, T. S., Clark, A. R., & Ham, J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2824-10.2010 · Cited by 76
AGR2 oncoprotein inhibits p38 MAPK and p53 activation through a DUSP10‐mediated regulatory pathway
Hrstka, R., Bouchalová, P., Michalová, E., Matoulková, E., Müller, P., Coates, P. J., & Vojtěšek, B. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.003 · Cited by 64
Habibian, J. S., & Ferguson, B. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010102 · Cited by 60
Kuang, E., Wu, F., & Zhu, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900025200 · Cited by 60
Rastogi, R., Jiang, Z., Ahmad, N., Rosati, R., Liu, Y., Beuret, L., Monks, R., Charron, J., Birnbaum, M. J., & Samavati, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.492702 · Cited by 65
Metadata
- Authors
- Jeffrey, K. L., Camps, M., Rommel, C., & Mackay, C. R.
- Affiliations
- Garvan Institute of Medical Research (AU)
- Merck Serono S.A. (Switzerland) (CH)
- Corresponding author
- Jeffrey, Kate L.
- Mackay, Charles R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2007-05
- Volume
- 6
- Issue
- 5
- Pages
- 391-403
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1971925780
- Cited by
- 533
- References
- 169
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 37 · 2023: 30 · 2022: 33 · 2021: 33 · 2020: 22 · 2019: 20 · 2018: 21 · 2017: 33 · 2016: 29 · 2015: 26 · 2014: 30 · 2013: 34 · 2012: 38
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- dual-specificity phosphatase, MAPK phosphatase, MAPK signaling, protein tyrosine phosphatase, immune regulation, therapeutic target, cancer immunotherapy, infectious diseases, inflammatory diseases
- MeSH terms
- Animals, Humans, Immunity, Phosphoric Monoester Hydrolases, Substrate Specificity, Signal Transduction, Protein Tyrosine Phosphatases, Mitogen-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.